CVS Health Co. (NYSE:CVS) Stock Holdings Lifted by Trinity Legacy Partners LLC

Trinity Legacy Partners LLC boosted its position in CVS Health Co. (NYSE:CVSGet Rating) by 8.9% during the 1st quarter, HoldingsChannel reports. The firm owned 29,060 shares of the pharmacy operator’s stock after buying an additional 2,385 shares during the quarter. Trinity Legacy Partners LLC’s holdings in CVS Health were worth $2,941,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently modified their holdings of CVS. West Bancorporation Inc. bought a new stake in CVS Health in the 4th quarter valued at about $25,000. Claremont Financial Group Inc. bought a new stake in CVS Health in the 4th quarter valued at about $26,000. Stuart Chaussee & Associates Inc. lifted its position in CVS Health by 123.0% in the 1st quarter. Stuart Chaussee & Associates Inc. now owns 310 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 171 shares during the last quarter. Capital Advisors Ltd. LLC lifted its position in CVS Health by 125.7% in the 4th quarter. Capital Advisors Ltd. LLC now owns 316 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 176 shares during the last quarter. Finally, Steph & Co. lifted its position in CVS Health by 138.7% in the 4th quarter. Steph & Co. now owns 358 shares of the pharmacy operator’s stock valued at $37,000 after purchasing an additional 208 shares during the last quarter. Hedge funds and other institutional investors own 78.00% of the company’s stock.

Shares of CVS opened at $91.29 on Thursday. CVS Health Co. has a one year low of $79.33 and a one year high of $111.25. The company has a 50-day moving average of $97.08 and a two-hundred day moving average of $101.42. The stock has a market cap of $119.71 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 1.44 and a beta of 0.78. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.88 and a quick ratio of 0.62.

CVS Health (NYSE:CVSGet Rating) last announced its earnings results on Wednesday, May 4th. The pharmacy operator reported $2.22 EPS for the quarter, topping the consensus estimate of $2.14 by $0.08. CVS Health had a net margin of 2.67% and a return on equity of 15.33%. The company had revenue of $76.83 billion during the quarter, compared to analysts’ expectations of $75.30 billion. During the same period last year, the company posted $2.04 earnings per share. The business’s revenue for the quarter was up 11.2% on a year-over-year basis. Analysts anticipate that CVS Health Co. will post 8.34 earnings per share for the current year.

Several analysts recently weighed in on the stock. Tigress Financial lifted their price objective on shares of CVS Health from $122.00 to $125.00 in a research report on Thursday, April 7th. Sanford C. Bernstein cut shares of CVS Health from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $122.00 to $112.00 in a research note on Thursday, May 26th. StockNews.com assumed coverage on shares of CVS Health in a research note on Thursday, March 31st. They set a “strong-buy” rating on the stock. Loop Capital assumed coverage on shares of CVS Health in a research note on Thursday, June 16th. They set a “buy” rating and a $120.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of CVS Health from $110.00 to $113.00 in a research note on Thursday, May 5th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average target price of $116.05.

In related news, EVP Prem S. Shah sold 5,346 shares of the firm’s stock in a transaction that occurred on Wednesday, March 30th. The shares were sold at an average price of $104.70, for a total transaction of $559,726.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Daniel P. Finke sold 55,359 shares of the firm’s stock in a transaction that occurred on Monday, April 4th. The stock was sold at an average price of $100.13, for a total transaction of $5,543,096.67. Following the sale, the executive vice president now owns 3,098 shares of the company’s stock, valued at $310,202.74. The disclosure for this sale can be found here. Over the last quarter, insiders sold 77,659 shares of company stock valued at $7,882,993. Corporate insiders own 0.69% of the company’s stock.

About CVS Health (Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Read More

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.